02.10.2023 08:15, Rita Longobardi
Since 2006, Venturelab has brought ten of the most innovative Swiss-based Medtech entrepreneurs to the US for an intensive business development program. Here you learn more about their US adventures.
The Swiss National Medtech Startup Team, known as the Venture Leaders Medtech, embarked on a 360º immersive journey from September 25 to 29 that didn't fail to meet their expectations. Their destination? The dynamic city of Boston, a hotbed of innovation and opportunity in the Medtech industry. This dedicated roadshow was nothing short of a game-changer for these ten high-potential startups, poised to make waves in the US market.
Handpicked after a fiercely competitive selection process, the team showcased an impressive array of startups destined for future success. Their action-packed week in Boston kicked off with a warm welcome from Swissnex Boston and a session exploring the intricacies of startup finance in the US with insights from Talal Ali Ahmad, Founder & CEO of Predictive Healthcare, setting the tone for what would be an extraordinary experience. They then received feedback from a panel of Medtech experts, including Edward Melia, Vinit Nijhawan, Hirak Parikh, Jeff Knox, and Sean J. Cheng. The day culminated in a reception at the Swiss Consul's Residence in Boston, hosted by Benjamin Bollmann.
The following days were filled with dedicated sessions featuring key players in the Medtech industry. They plunged into regulatory consultation with MCRA, witnessed revolutionary technology at Portal Instruments, and tapped into the vast network of MassMEDIC, the largest regional Medtech association in the United States. A workshop led by Nicolas Mosimann, a partner at Kellerhals Carrard, provided very useful glimpses.
The day concluded with the Medtech Cruise, offering our Venture Leaders the opportunity to pitch their solutions against the backdrop of Boston's scenic waters.
The final two days featured engaging panel discussions led by experts from Helbling Technik and Beacon Venture Partners, enhancing the knowledge and networking of the Swiss Medtech startups.
Of course, no journey to Boston would be complete without a sailing excursion in Boston Bay. This relaxing outing allowed our entrepreneurs to engage in meaningful discussions, reflect on the event's most critical highlights, and draw key takeaways that will undoubtedly shape their path to success.
The Venture Leaders Medtech's roadshow in Boston was more than just a trip; it was an impactful experience that will fuel their growth and drive their innovations forward in the dynamic world of Medtech entrepreneurship.
Venturelab has been organizing international roadshows for the Swiss National Startup Teams for 18 years. The ambitious entrepreneurs and their promising startups are introduced to top-class investors and potential customers in leading technology hubs such as Silicon Valley, Boston, New York, London, Munich, Shanghai, Beijing, Shenzhen, and Barcelona. The Venture Leaders Medtech program is organized by Venturelab in collaboration with Swissnex Boston, and supported by EPFL Lausanne, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, and Canton of Vaud.
Learn more about the Venture Leaders Medtech 2023 startups below:
Artiria Medical SA:
A new standard of care to fight stroke and save lives.
Artiria Medical is revolutionising neurovascular healthcare with cutting-edge minimally invasive medical technologies. Our first product, an innovative FDA-cleared wire with a micro-articulated seekin... Read more
biped robotics SA:
All-in-one navigation device for blind people
40 million people in the world are fully blind. biped is the world's first AI copilot for blind and visually impaired people.
The device is worn on the shoulders, like a harness. It is equipped with ... Read more
HeroSupport SA:
Personalized breast immobilization shells for radiotherapy.
HeroSupport revolutionizes patient immobilization in radiation therapy, especially for breast cancer. Unlike traditional methods, we provide custom fit "shells" for precise patient positioning during ... Read more
KOVE medical AG:
Prevents fetal membrane rupture following fetoscopies.
KOVE develops a device to seal and fix the hole created by the surgical tools used to treat fetuses during pregnancy. By closing this hole, KOVE decreases dramatically the risk of preterm birth, which... Read more
mimiX Biotherapeutics SA:
We Re-Define Regenerative Medicine with Acoustic 3Dprinting
Swiss startup mimiX Biotherapeutics is revolutionizing the bioprinting skin product industry with a cutting-edge technology. FastSkin® tissue is an advanced dermal substitute for treating acute and ch... Read more
NeoPredics AG:
Predictive analytics for neonatal and maternal applications
NeoPrediX develops decision support tools (software-as-a-service) with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We u... Read more
PeriVision SA:
Helping eye doctors save vision with AI, VR, and the cloud.
We are a highly visual species, but 2.2 billion people suffer from vision impairments. 50% of these could be prevented or cured with timely diagnosis or treatment. We combine AI, VR & the cloud to bui... Read more
Pipra AG:
Reducing the burden of delirium through digitalization.
PIPRA is launching an AI-based postoperative delirium (POD) risk stratification tool, which at last allows implementation of the POD prevention guidelines to work in the real world. Health care profes... Read more
Regenosca:
Regenosca Seamless Tissue Regeneration
Regenosca provides regenerative medicine technology that enables permanent regrowth of your own native tissues on a self-absorbing mesh, ensuring seamless healing of soft tissue defects and surgical w... Read more
Testmate Health SA:
Low-cost accurate molecular tests from point-of-care to home
Testmate Health has microengineered the power of a PCR machine into a low-cost, single-use disposable, test that can detect any DNA or RNA sequence with immediate results from the point-of-care to at-... Read more